MedTrace Logo

Initiation of Continuous Glucose Monitoring at Diagnosis of Type 1 Diabetes

NCT02734667 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2022-03-02

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to learn about the impact of continuous glucose monitoring (CGM) on families with newly diagnosed children with type 1 diabetes (T1D). The investigators hope to learn about how continuous glucose monitoring affects glycemic variables and diabetes-related distress.

Conditions

  • Type 1 Diabetes Mellitus

Interventions

DEVICE

CGM at diagnosis of T1D

Initiation of non-adjunctive CGM use at diagnosis of T1D

Sponsors & Collaborators

  • University of Colorado, Denver

    collaborator OTHER

  • Korey Hood

    lead OTHER

Principal Investigators

  • Korey K Hood, PhD · Stanford University

  • Bruce Buckingham, MD · Stanford University

  • Paul Wadwa, MD · University of Colorado, Denver

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2020-02-29
Completion
2020-02-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02734667 on ClinicalTrials.gov